Portfolio company
Glympse Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops tunable biosensor platforms and injectable nanoparticles for non-invasive disease monitoring and diagnostic testing for pharmaceutical companies and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
LynxBiosciences
This biotechnology company develops cellular assays and microfluidic platforms to predict clinical drug responses for oncology patients and pharmaceutical developers.
Fyr Bio
This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
GLX Analytix
This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.
Causeway Sensors
This company develops plasmonic nanostructure sensors for real-time bioprocess monitoring and drug manufacturing data collection for pharmaceutical companies.
Hone Bio
This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
